Celldex Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $730 | $695 | $1,175 | $3,191 |
Gross Profit | 730 | 695 | 356 | 3,191 |
EBITDA | -62,984 | -61,872 | -55,208 | -51,340 |
EBIT | -63,857 | -62,739 | -56,027 | -52,126 |
Net Income | -56,600 | -53,796 | -47,092 | -42,121 |
Net Change In Cash | 730 | 695 | 1,175 | 3,191 |
Free Cash Flow | -44,733 | -54,372 | -33,232 | -54,719 |
Cash | 23,044 | 17,136 | 28,356 | 36,399 |
Basic Shares | 66,392 | 66,383 | 66,352 | 66,294 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $7,020 | $6,883 | $2,357 | $4,651 |
Gross Profit | 7,020 | -111,128 | -79,901 | 1,583 |
EBITDA | -191,901 | -139,034 | -104,200 | -66,080 |
EBIT | -195,078 | -142,042 | -107,096 | -69,148 |
Net Income | -157,863 | -141,429 | -112,325 | -70,511 |
Net Change In Cash | 7,020 | 6,883 | 2,357 | 4,651 |
Cost of Revenue | -4,693 | |||
Free Cash Flow | -159,697 | -109,109 | -105,560 | -62,158 |
Cash | 28,356 | 34,814 | 29,429 | 39,143 |
Basic Shares | 64,395 | 48,449 | 46,888 | 42,870 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.85 |
2025-03-31 | -$0.81 |
2024-12-31 | -$0.71 |
